Most cell therapies in development use a T cell or some other type of immune cell that’s engineered to perform a particular therapeutic task. Rubius Therapeutics makes its cell therapies from red ...

The Spanish-Norwegian influencer Rubén Doblas Gundersen will launch the new gaming show 'Rubius Checkpoint' on the new streaming platform next year. By Scott Roxborough Europe Bureau Chief Rubén ...

Rubius Therapeutics has torn up its strategy. After reviewing human data on its lead candidates, the cell therapy biotech concluded investment in its two clinical prospects “is no longer justified,” ...

Rubius Therapeutics has pulled in another $100 million to fund the advance of its red blood cell therapies. The crossover round, which brings Rubius’ nine-month haul up to $220 million, comes as the ...

Rubius Therapeutics shares surged 84% during Monday's trading session. The biotech firm outlined encouraging data from testing of RTX-240, a potential cancer treatment. Rubius said data collected ...

Rubius Therapeutics, Inc. (RUBY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...

In November 2022, Rubius Therapeutics Inc (NASDAQ: RUBY) initiated a process to explore a range of strategic alternatives and planned to engage an investment bank to act as a strategic advisor. But ...

El Rubius did not just walk away from MrBeast’s $1 million streamer challenge. He opened up. Soon after his elimination, the Spanish creator shared a raw reaction with fans, giving them a closer look ...

Add Yahoo as a preferred source to see more of our stories on Google. CANNES — Telefonica’s Movistar +, the biggest drive into original series production by any telecom in Europe, hinted at some of ...

In a phase 1/2 clinical trial for RTX-240 on patients with advanced solid tumors, the therapy showed encouraging safety and efficacy signs, as demonstrated by initial clinical data revealed by the ...